Literature DB >> 3731151

Phase II trial of bisantrene in patients with metastatic melanoma.

C Mackel, F L Meyskens, D S Alberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3731151

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

Authors:  B G Durie; J Crowley; C A Coltman; R A Chapman; S P Balcerzk; J D Bonnet; D A Lipschitz; R L Stephens; B D Cheson
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

2.  Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group Study.

Authors:  D S Alberts; N Mason-Liddil; S J Green; J D Cowan; W S Fletcher; B Neilan; J T Guy; R B Epstein
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.